Key players include major biotechnology firms and manufacturers focusing on reagents for fluorescence, microscopy, and other imaging modalities. The trend for specificity and sensitivity of products to cater to the differentiated needs in the biological imaging reagents market is propelling growth. For instance, in July 2024, the imaging segment of GE HealthCare reported revenues of USD 2.5 billion for the second quarter of last year and reflected flat revenue growth of USD 2.62 billion in organic imaging. The imaging EBIT grew by 3% to reach USD 286 million.
Major contributors are:
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?